Busulfan Disease Interactions
There are 4 disease interactions with busulfan.
Busulfan (applies to busulfan) infections
Major Potential Hazard, High plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral
Busulfan can induce severe and prolonged myelosuppression. Treatment with busulfan should not be initiated in patients with known infectious diseases. All patients should be instructed to immediately report any signs or symptoms suggesting infection such as fever, sore throat, or local infection during therapy with busulfan. Close clinical monitoring of hematopoietic function is recommended.
References
- (2001) "Product Information. Myleran (busulfan)." Prasco Laboratories
Busulfan (applies to busulfan) myelosuppression
Major Potential Hazard, High plausibility. Applicable conditions: Bone Marrow Depression/Low Blood Counts, Fever, Bleeding
Busulfan induces severe and prolonged myelosuppression at the recommended dosage. Hematopoietic progenitor cell transplantation is required to prevent potentially fatal complications of the prolonged myelosuppression. It is recommended to closely monitor complete blood counts, including white blood cell differentials, and quantitative platelet counts daily during treatment and until engraftment is demonstrated. Extreme caution should be exercised if busulfan is administered in patients whose bone marrow reserve may be compromised by prior irradiation or chemotherapy or whose marrow function is recovering from previous cytotoxic therapy. Patients should be instructed to immediately report any signs or symptoms suggesting bone marrow suppression, such as fever, sore throat, local infection, bleeding, or symptoms of anemia.
References
- Fernandez LA, Zayed E (1988) "Busulfan-induced sideroblastic anemia." Am J Hematol, 28, p. 199-200
- (2001) "Product Information. Myleran (busulfan)." Prasco Laboratories
Busulfan (applies to busulfan) cardiac tamponade
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Thalassemia
Cardiac tamponade during high dose busulfan therapy combined with cyclophosphamide has been reported in pediatric patients with thalassemia. Abdominal pain and vomiting may precede the tamponade. Cardiac tamponade can result in death and therapy with busulfan should be administered cautiously to patients with thalassemia.
References
- (2001) "Product Information. Myleran (busulfan)." Prasco Laboratories
Busulfan (applies to busulfan) seizure disorders
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Head Injury, Seizures
Seizures have been reported in patients receiving high doses of busulfan. Therapy with busulfan should be administered cautiously to patients with a history of a seizure disorder or head trauma or who are receiving other potentially epileptogenic drugs.
References
- (2001) "Product Information. Myleran (busulfan)." Prasco Laboratories
Busulfan drug interactions
There are 284 drug interactions with busulfan.
More about busulfan
- busulfan consumer information
- Check interactions
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.